Cargando…

Synchronous carotid body and anterior mediastinal paraganglioma revealed by (18)F-fluorodeoxyglucose and (68)Ga-DOTA(0)-Tyr(3)-octreotate positron emission tomography-computed tomography

Detalles Bibliográficos
Autores principales:	Xie, Hangyu, Lin, Hua, Li, Lin, Zhang, Wenjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240021/ https://www.ncbi.nlm.nih.gov/pubmed/37284100 http://dx.doi.org/10.21037/qims-22-1018

Ejemplares similares

Dynamic (68)Ga-DOTA(0)-Tyr(3)-octreotate positron emission tomography-computed tomography for the evaluation of pancreatic neuroendocrine tumors: a pilot study
por: Yin, Hongyan, et al.
Publicado: (2023)

Rapid kit-based (68)Ga-labelling and PET imaging with THP-Tyr(3)-octreotate: a preliminary comparison with DOTA-Tyr(3)-octreotate
por: Ma, Michelle T., et al.
Publicado: (2015)

Comparison of (68)Ga-DOTA-NaI(3)-Octreotide/tyr(3)-octreotate positron emission tomography/computed tomography and contrast-enhanced computed tomography in localization of tumors in multiple endocrine neoplasia 1 syndrome
por: Patil, Virendra A., et al.
Publicado: (2020)

Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor
por: Schmidt, Matthew Q, et al.
Publicado: (2019)

Validation of Quality Control Parameters of Cassette-Based Gallium-68-DOTA-Tyr3-Octreotate Synthesis
por: Sammartano, Antonino, et al.
Publicado: (2020)

Inflammatory Myofibroblastic Tumor: Findings on (68)Ga-DOTA-NOC Positron-emission Tomography-Computed Tomography
por: Tripathy, Sarthak, et al.
Publicado: (2020)

Hypoglycemia-Triggered Motion Artifact on (68)Ga-DOTA-TOC Positron Emission Tomography/Computed Tomography
por: Chandra, Piyush, et al.
Publicado: (2021)

Effects of therapy with [(177)Lu-DOTA(0),Tyr(3)]octreotate on endocrine function
por: Teunissen, Jaap J. M., et al.
Publicado: (2009)

(68)Ga-Tetraazacyclododecane Tetraacetic Acid-DPhe1-Tyr3-Octreotate Positron Emission Tomography/Computed Tomographic Findings of Large-Cell Neuroendocrine Carcinoma of the Lung in a Child
por: Filizoglu, Nuh, et al.
Publicado: (2022)

Pancreatic serous cystoadenoma (CSA) showing increased tracer uptake at 68-GaDOTA-peptide Positron Emission Tomography (68Ga-DOTA-peptide PET-CT): a case report
por: Nappo, Gennaro, et al.
Publicado: (2020)

(68)Ga-DOTA-E-[c(RGDfK)]2 positron emission tomography–computed tomography in the evaluation of hepatic hemangioendothelioma epithelioid
por: Soldevilla-Gallardo, Irma, et al.
Publicado: (2019)

Bone marrow dosimetry in peptide receptor radionuclide therapy with [(177)Lu-DOTA(0),Tyr(3)]octreotate
por: Forrer, Flavio, et al.
Publicado: (2009)

Influence of tumour size on the efficacy of targeted alpha therapy with (213)Bi-[DOTA(0),Tyr(3)]-octreotate
por: Chan, Ho Sze, et al.
Publicado: (2016)

Correlation between Standardized Uptake Value of (68)Ga-DOTA-NOC Positron Emission Tomography/Computed Tomography and Pathological Classification of Neuroendocrine Tumors
por: Kaewput, Chalermrat, et al.
Publicado: (2018)

Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate
por: de Keizer, Bart, et al.
Publicado: (2008)

Salvage peptide receptor radionuclide therapy with [(177)Lu-DOTA,Tyr(3)]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours
por: van der Zwan, W. A., et al.
Publicado: (2018)

Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [(177)Lu-[DOTA0, Tyr3]-octreotate
por: Santoro, Lore, et al.
Publicado: (2018)

177Lu-DOTA-0-Tyr3-octreotate infusion modeling for real-time detection and characterization of extravasation during PRRT
por: Mazzara, Christophe, et al.
Publicado: (2022)

Graves' Ophthalmopathy on (68)Ga-DOTANOC Positron Emission Tomography/Computed Tomography
por: Arora, Saurabh, et al.
Publicado: (2019)

Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate
por: Bergsma, Hendrik, et al.
Publicado: (2016)

Incidental Meningioma on (68)Ga-DOTANOC Positron-Emission Tomography
por: Parihar, Ashwin Singh, et al.
Publicado: (2018)

Phase I study of the (177)Lu-DOTA(0)-Tyr(3)-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung
por: Kim, Chul, et al.
Publicado: (2020)

Cellular dosimetry of [(177)Lu]Lu-DOTA-[Tyr(3)]octreotate radionuclide therapy: the impact of modeling assumptions on the correlation with in vitro cytotoxicity
por: Tamborino, Giulia, et al.
Publicado: (2020)

Corticomedullary Mixed Tumor of the Adrenal Gland with Apparent (18)F-Fluorodeoxyglucose Activity But No (68)GA-DOTATATE Uptake on Positron Emission Tomography/Computed Tomography
por: Engur, Ceren Ozge, et al.
Publicado: (2022)

Castleman Disease Masquerading as the Posterior Mediastinal Mass on (18)F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
por: Gupta, Vanshika, et al.
Publicado: (2019)

[(18)F]fluorodeoxyglucose positron emission tomography/computed tomography characteristics of primary mediastinal germ cell tumors
por: Lee, Koeun, et al.
Publicado: (2023)

Castleman disease of the pancreas mimicking pancreatic malignancy on (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography: A case report
por: Liu, Sheng-Lu, et al.
Publicado: (2022)

Changes in biodistribution on (68)Ga-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression
por: Cherk, Martin H., et al.
Publicado: (2018)

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate
por: Kwekkeboom, D. J., et al.
Publicado: (2003)

(68)Ga-DOTATATE-positron emission tomography imaging in spinal meningioma
por: Slotty, Philipp Jörg, et al.
Publicado: (2014)

Spinal molecular imaging by (68) Ga-DOTATATE-positron emission tomography
por: Sandu, Nora, et al.
Publicado: (2014)

(68)Ga-bisphosphonates for the imaging of extraosseous calcification by positron emission tomography
por: Keeling, George P., et al.
Publicado: (2023)

Failure of functional imaging with gallium-68-DOTA-D-Phe1-Tyr3-octreotide positron emission tomography to localize the site of ectopic adrenocorticotropic hormone secretion: a case report
por: Gani, Linsey U, et al.
Publicado: (2011)

Diffuse nesidioblastosis diagnosed on a Ga-68 DOTATATE positron emission tomography/computerized tomography
por: Arun, Sasikumar, et al.
Publicado: (2013)

Ga-68 DOTATATE Positron Emission Tomography/Computed Tomography in a Rare Case of Esthesioneuroblastoma
por: Verma, Priyanka, et al.
Publicado: (2021)

Malignant Tracheoparenchymal Fistula in Primary Mediastinal B-Cell lymphoma detected on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
por: Singh, Vijay, et al.
Publicado: (2022)

Utility of (18)F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging in the Diagnosis of Cardiac Paraganglioma
por: Bhojwani, Nicholas, et al.
Publicado: (2017)

68Ga-DOTA-D Phe1-Tyr3-Octreotide (DOTATOC)-PET/CT in a Suspected Case of Recurrent Meningioma
por: Jain, Sachin, et al.
Publicado: (2017)

[(68)Ga]Ga-DOTA-TOC: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging
por: Hennrich, Ute, et al.
Publicado: (2020)

Molecular Imaging to the Surgeons Rescue: Gallium-68 DOTA-Exendin-4 Positron Emission Tomography-Computed Tomography in Pre-operative Localization of Insulinomas
por: Pallavi, UN, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_erksua7ivohc8uuku5kqbst0pi